Finally, as the genomic DNA in whole blood is of primarily hematopoietic origin, we sought to assess whether ALT-TFs are detected in cell-free DNA data from cancer patients but not in healthy individuals, which would thus be consistent with the somatic origin of ALT-TFs. The gene discussed is GPT; the disease is cancer.